When MG was treated as the exposure, MR evidence suggested a causal relationship between MG and T1DM, SLE, AITD (both hypothyroidism and hyperthyroidism), and MS (excluding RA).

• 113
• 0
• 0
• 0

The limit of whole-body MRI in assessing myasthenia gravis is its poor spatial resolution for evaluating retroorbital muscles. In this case, the MRI focused on the orbital region is an excellent imaging tool for the evaluation of extraorbital muscle involvement.

• 8
• 0
• 0
• 0

The treatment of MG has changed from traditional drug therapies, such as AChEI and corticosteroids, to novel therapies using biologicals, such as B- and T-cell targeted immunotherapies, complement inhibitor therapy, FcRn inhibitor therapy, and stem cell therapy.

• 77
• 0
• 0
• 0

Because the efficient treatment of neuroendocrine neoplasia (NEN) is instrumental in achieving a complete remission of myasthenia gravis, screening for rare neuroendocrine malignancies, including pancreatic NEN, could be considered in the diagnostic evaluation.

• 16
• 0
• 0
• 0